Suchergebnisse - "YO603Y8113"

PubPharm (1.117)

101

Design and evaluation of novel piperidine HIV-1 protease inhibitors with potency against DRV-resistant variants

enthalten in: European journal of medicinal chemistry | 2021

von Zhu, M. | Zhou, H. | Ma, L. | +7

102

Changes in lipidomic profile by anti-retroviral treatment regimen : An ACTG 5257 ancillary study

enthalten in: Medicine | 2021

von Chaudhary, N. | Kind, T. | Willig, A. | +6

103

Dolutegravir or Darunavir in Combination with Zidovudine or Tenofovir to Treat HIV

enthalten in: The New England journal of medicine | 2021

von Paton, N. | Musaazi, J. | Kityo, C. | +97

104

Multiple Computational Approaches for Predicting Drug Interactions with Human Equilibrative Nucleoside Transporter 1

enthalten in: Drug metabolism and disposition: the biological fate of chemicals | 2021

von Miller, S. | Lane, T. | Zorn, K. | +3

105

Virological response and resistance profile in highly treatment-experienced HIV-1-infected patients switching to dolutegravir plus boosted darunavir in clinical practice

enthalten in: HIV medicine | 2021

von Armenia, D. | Bouba, Y. | Gagliardini, R. | +10

106

Pharmacokinetics of darunavir and cobicistat in pregnant and postpartum women with HIV

enthalten in: AIDS (London, England) | 2021

von Momper, J. | Wang, J. | Stek, A. | +15

107

Fixed-dose darunavir/cobicistat in pregnancy of HIV-infected women, pharmacokinetic concerns

enthalten in: AIDS (London, England) | 2021

von Dash, P. | Boix, V.

108

Authors' Reply to Cattaneo et al. : "Comment on: Comparative Population Pharmacokinetics of Darunavir in SARS-CoV-2 Patients vs. HIV Patients: The Role of Interleukin6"

enthalten in: Clinical pharmacokinetics | 2021

von Cojutti, P. | Londero, A. | Della Siega, P. | +5

CommentOn: Clin Pharmacokinet. 2021 Jun;60(6):829-831. - PMID 33864625

109

Comment on "Comparative Population Pharmacokinetics of Darunavir in SARS-CoV-2 Patients vs. HIV Patients : The Role of Interleukin-6"

enthalten in: Clinical pharmacokinetics | 2021

von Cattaneo, D. | Corbellino, M. | Cozzi, V. | +2

CommentOn: Clin Pharmacokinet. 2020 Oct;59(10):1251-1260. - PMID 32856282

110

Systematic analysis of safety profile for darunavir and its boosted agents using data mining in the FDA Adverse Event Reporting System database

enthalten in: Scientific reports | 2021

von Tian, X. | Yao, Y. | He, G. | +3